Ryan C. Fisher - 06 Jul 2026 Form 4 Insider Report for Ingevity Corp (NGVT)

Reporting relationship: SVP, Gen. Counsel & Secretary
Issuer ticker: NGVT
Reported as of: 06 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jul 2026, 17:07:35 UTC
Prior SEC filing: 27 Mar 2026
Source filing: View source filing
Reporting owner signature: Ryan C. Fisher By: Mavis Huger as Attorney-in-Fact

Key filing fact

Ryan C. Fisher filed Form 4 for Ingevity Corp (NGVT) on 08 Jul 2026.

Key facts

This page summarizes Ryan C. Fisher's Form 4 filing for Ingevity Corp (NGVT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Jul 2026, 17:07.

Change

Previous filing in this sequence was filed on 27 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002017486 Primary reporting owner

Fisher Ryan C.

Relationship: SVP, Gen. Counsel & Secretary
Address: C/O INGEVITY CORPORATION, 4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON
Signature: Ryan C. Fisher By: Mavis Huger as Attorney-in-Fact
Signature date: 08 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NGVT transaction

Common Stock

Tax liability

Transaction value
Shares: -168
Change %: -0.9%
Price: $73.86^*
Shares after: 18,431
Date: 06 Jul 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares withheld by the Company to satisfy tax withholding obligations related to the 2024 RSUs that vested.

Footnote F2

Includes (i) 329 shares of Common Stock purchased pursuant to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, as amended ("ESPP") for the purchase period of January 1, 2026 to March 31, 2026 (the "March ESPP Shares"), and (ii) 76 shares of Common Stock purchased pursuant to the ESPP for the purchase period of April 1, 2026 to June 30, 2026 (the "June ESPP Shares"). In accordance with the terms of the ESPP, the March ESPP Shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on December 31, 2025 and the June ESPP Shares were purchased at a price equal to 85% of the closing price of the Issuer's Common Stock on April 1, 2026.